Blogs y actualizaciones
Nuestros blogs explican las afecciones de salud y la investigación clínica de una manera fácil de entender, para que los lectores se sientan más informados.
La crisis mundial de obesidad en el mundo actual
Imagine walking into a crowded room and realizing that nearly 2 out of every 5 people are battling obesity. It’s not just a personal struggle. It’s, a global health crisis affecting over 650 million adults worldwide. Obesity doesn’t just impact how...
Comprender y controlar los niveles altos de triglicéridos: diagnóstico y opciones de tratamiento
Understanding and Managing High Triglycerides: Diagnosis and Treatment Options Triglycerides and cholesterol are related because they work similarly in the body. Triglycerides are a type of fat in your blood that gives you energy. When you eat, any extra calories get...
Técnicas no invasivas para el diagnóstico de MASH
Metabolic dysfunction-associated steatohepatitis (MASH) is a liver condition where fat builds up in the liver, causing inflammation and damage. Unlike liver issues caused by alcohol, MASH is linked to problems like obesity, diabetes, and high cholesterol. If left untreated, MASH can...
Exploración de la microbiota intestinal en pacientes con colitis ulcerosa y depresión: un estudio piloto
Ulcerative colitis (UC) is a chronic inflammatory bowel disease, that leads to inflammation and ulcers in the colon and rectum, with its exact causes still unclear. In recent years, the incidence of UC has been rising steadily in Asia, with China...
How RSV Research Keeps Kids Safe and Free to Explore
What is RSV? Respiratory Syncytial Virus (RSV) is a common virus that can spread quickly, especially among infants and young children. While it often shows up as symptoms that resemble a common cold—like a runny nose, coughing, wheezing, and difficulty breathing—it...
Resmetirom: una nueva y prometedora frontera en la terapia MASH
Fatty liver, an increasing global health concern Metabolic dysfunction-associated steatotic liver disease (MASLD), commonly referred to as fatty liver disease, is becoming a global health concern, with over 30% of adults affected. In regions like South America and the Middle East,...
How Diet Affects Crohn’s Disease Management: Insights from Recent Medical Studies
Crohn’s disease is a chronic inflammatory disease of the gastrointestinal tract that might lead to progressive bowel damage and disability1. Affecting millions of people worldwide. While medication and surgery are common treatments, diet plays a crucial role in managing symptoms and...
How Ophthalmology Clinical Trials Contribute to Vision Care and Eye Health
Clinical trials are the cornerstone of medical advancements, playing a critical role in the development of new treatments and therapies. In ophthalmology, these trials are significant, as they contribute to improving vision care and eye health. This article explores the importance...
Desarrollo de la vacuna contra el VSR: estudios actuales y avances
Respiratory Syncytial Virus (RSV) is a major cause of respiratory illness in infants, young children, and older adults1. Despite decades of research, there is still little available vaccine for RSV. However, recent advancements in vaccine development2 are bringing hope for effective prevention strategies....
High-Risk Groups: Why Older Adults Are Most Vulnerable to RSV
Respiratory Syncytial Virus (RSV) is a common virus that infects the respiratory tract1, often causing mild, cold-like symptoms. While it frequently affects children2, RSV can lead to severe illness3 and even hospitalization in older adults4. Understanding why older adults are at...
Key Eligibility Criteria for MASH Clinical Trials: Who Can Participate?
Metabolic dysfunction-associated steatohepatitis (MASH)1 previously known as Non-alcoholic steatohepatitis (NASH) is a serious liver condition that has been gaining attention due to its increasing prevalence2,3 and the limited number of FDA-approved treatments. The global prevalence of Metabolic dysfunction- associated fatty liver...
La lucha oculta: cómo la fibrosis está redefiniendo el futuro del tratamiento de la MASH (esteatohepatitis asociada a disfunción metabólica)
Imagine your body as a bustling city where everything works seamlessly, maintaining the delicate balance of health. Now, think of non-alcoholic steatohepatitis (NASH) or Metabolic dysfunction-associated steatohepatitis (MASH) as an insidious construction project gone wrong inside this city, gradually laying down...










